Glycogen Metabolism Predicts the Efficacy of Immunotherapy for Urothelial Carcinoma

Glycogen Metabolism Predicts the Efficacy of Immunotherapy for Urothelial Carcinoma

Urothelial cancer (UC) is one of the common refractory tumors and chemotherapy is the primary treatment for it. The advent of immune checkpoint inhibitors (ICI) has facilitated the development of treatment strategies for UC patients. To screen out UC patients sensitive to ICI, researchers have propo...

Full description

Bibliographic Details
Main Authors: Yueming Zhang, Xuechun Li, Rui Zhou, Anqi Lin, Manming Cao, Qingwen Lyu, Peng Luo, Jian Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Pharmacology
Subjects:
urothelial cancer
glycogen metabolism
immunotherapy
prognosis
gene mutation
immune microenvironment
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.723066/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.723066/full

Similar Items